Search

The article discusses glaucoma which is among the top three causes of blindness worldwide. It notes that about 1.6 million people aging 40 years and older in the U.S. have glaucoma. It also cites the two main forms of glaucoma such as open-angle glaucoma, and angle-closure glaucoma. Among its causative factors include elevated intraocular pressure levels, thin corneas, and steroid use. Moreover, it indicates the use of perimetry to diagnose the condition. INSETS: New Thinking on Angle-Closure Glaucoma;How to Apply Your Glaucoma Eyedrop;Coping with the Cost of Glaucoma Medication.

The article focuses on the study which describes the treatment of glaucoma in the U.S. The primary objective in treating glaucoma, both open-angle and closed-angle glaucoma, is to reduce and prevent optic nerve damage through intraocular pressure (IOP) lowering and maintain a certain level that would stop further nerve damage. It states that selecting glaucoma treatment involves health benefits and risk factors. The primary treatment alternatives for glaucoma are discussed. INSET: Glaucoma Guidelines Often Ignored.

The article focuses on the procedure and standardization in conducting glaucoma diagnosis in the U.S. In diagnosing the disease, an eye examination is performed to measure intraocular pressure (IOP), citing optic nerve damage and testing visual fields. Ophthalmologists use three kinds of tests in making glaucoma diagnosis and treatment response including tonometry, ophthalmoscopy and perimetry

The article provides information on treating glaucoma. The important method in treating glaucoma is to prevent optic nerve damage by lowering intraocular pressure (IOP) and to keep it from further damages. The treatment should also consider the health benefits and dangers of each alternative while minimizing financial costs. INSET: Vision Restoration Therapy.

The article provides information on diagnosing glaucoma. The eye examination for glaucoma involves not only intraocular pressure (IOP) measurement but also with the association of other tests. The three types of tests used by the ophthalmologists in diagnosing the disease include tonometry, opthalmoscopy and perimetry. INSET: Vision and Mobility.

The article focuses on the treatment of glaucoma. Open-angle glaucoma can be treated safely and effectively with medication or surgery. Lifelong use of medication is necessary. However, acute closed-angle glaucoma is a medical emergency. The goal of treating glaucoma is to prevent damage to the optic nerve by lowering the intraocular pressure. INSETS: Consider Drug Side Effects;Exercise and Glaucoma.

The article focuses on the diagnosis of glaucoma. Measurement of the intraocular pressure, viewing of the optic nerve and testing of the visual fields are the examination for glaucoma. The tests include tonometry, air-puff tonometry, ophthalmoscopy, and perimetry. IOP measurements alone are no longer used to diagnose glaucoma.

Provides information about glaucoma. Survey on the totality of Americans with glaucoma; Risk of glaucoma varies with race and age; Role of intraocular pressure in the development of glaucoma. INSETS: How Glaucoma Affects Vision;Medications That May Cause Vision Problems.

The article provides information on Glaucoma, a disease of the optic nerve, in which the nerve cells in the front of the optic nerve dies. The early sign of glaucoma is elevated intraocular pressure (IOP). IOP may lead to glaucoma due to other reasons such as: diabetes, high blood pressure, migraine, hypothyroidism, sleep apnea, eye injury, extreme nearsightedness and the use of corticosteroids. It is also important to consider the function of aqueous humor in relation to glaucoma research.

The article discusses the diagnosis for glaucoma. It mentions that glaucoma diagnosis involves an eye examination that measures intraocular pressure (IOP), inspects the optic nerve and test the patients visual fields. It notes that ophthalmologists use several test screen glaucoma and monitor response to treatment, which includes tonometry, ophthalmoscopy and perimetry.

The article focuses on the methodology used to prevent glaucoma disease in the U.S. Drugs or surgery is described as the most common method used in preventing the disease. The Ocular Hypertension Treatment Study discovers that 4% of people who undergo intraocular pressure (IOP)-lowering treatment developed glaucoma as compared to 10% of those who refused to take the procedure. The study reveals that IOP-lowering eyedrops help change the development of glaucoma treatment. INSET: Glaucoma: A Family Matter.

The article provides information about causes of glaucoma, an eye disease resulted from intraocular pressure (IOP). Glaucoma is caused by thin corneas and optineurin that will possibly lead to blindness. Other types of glaucoma include open-angle glaucoma and closed-angle glaucoma which are due to blockage, heredity and medications.

The article focuses on the causes of glaucoma. Thinner than normal corneas can make intraocular pressure measurements may be a risk factor for glaucoma. Corneal thickness should be measured. Defects in the optineurin gene may be associated with glaucoma. Optineurin directs the production of another protein found in trabecular network and retina.

The article discusses the ways and methods used for the treatment of glaucoma. It mentions that glaucomas can often be treated safely and effectively with proper medication, such as eye drops, and surgery. It also notes that the condition can be treated with regular visit to ophthalmologists and measurement of intraocular pressure and visual fields.

The article presents the symptoms of glaucoma. It states that open-angle and closed-angle glaucoma occurs when the intraocular pressure (IOP) rises rapidly to a dangerous level. It mentions that the signs and symptoms of the glaucoma attack are severe pain in the eye, nausea and vomiting, blurred vision and a rainbow-colored halos around lights.

The article presents the genetic causes of glaucoma. It states that one of the main risk for glaucoma is the elevated pressure because the fluids cannot drain properly due to the blockage of the filtering tubes of the eye. It also mentions that the blockage of the trabecular meshwork of the eye puts pressure on the optic nerve which leads to elevated intraocular pressure (IOP) and blindness. The best way to treat glaucoma is to take the IOP-lowering medications as directed.

Provides information regarding anatomy of the eye. Composition of iris; Function of retina; Role of intraocular pressure in the eye.

The article presents an answer to a question on what is intraocular pressure and its normal level.

The article presents the methods of preventing glaucoma. It states that glaucoma can be prevented through medications and surgery. A study called the Ocular Hypertension Treatment, mentions that open-angle and closed-angle glaucoma can be avoided through the intraocular pressure (IOP)-lowering eyedrops .

The article presents information on glaucoma. It states that glaucoma is the second leading cause of adult blindness that results from the intraocular pressure (IOP) that is too high for the optic nerve to endure. It mentions that glaucoma is more common in blacks and Hispanics than in whites and it is rampant with increasing age. In addition, glaucoma can lead to blindness caused by the damage to the optic nerve.

The article focuses on the study which shows the response of both black and white people to glaucoma treatment in the U.S. The primary goal of the study is to examine the impact of ethnicity on treatment response. The study reveals that both races have responded with same levels to the medications. According to the study, the selection of intraocular pressure (IOP)-lowering treatment should be based on patient medical history, doses scheduling and side effects.

The article focuses on the study which shows that intraocular pressure (IOP) fluctuation can affects vision clarity in people with glaucoma in the U.S. Ophthalmologists confirms that even people with normal life may experience IOP fluctuation, which could affect their vision field. The study suggests that people with at least two standard deviations of IOP fluctuation need to have both medications and regular eye examinations.

The article presents the study conducted by the New York City-based researchers regarding the importance of 24-hour monitoring in improving glaucoma treatment. Researchers administered the study to 32 seated patients to determine if the whole day monitoring can give a more reliable representation of the intraocular pressure (IOP) fluctuations. The study revealed that the monitoring is important because the risks for pressure fluctuations in the eyes can increase during night time.

The article provides information on how to prevent glaucoma. The methods used in preventing the disease include administration of drugs or surgery. In an open-angle glaucoma, the study shows that the use of intraocular pressure (IOP)-lowering eyedrops can delay glaucoma development. In close-angle glaucoma, holing the iris with a laser is the suggested treatment in preventing the disease.

The article presents the study conducted by the Dalhousie University researchers regarding the relations between corneal thickness and glaucoma in Halifax, Nova Scotia. The study conducted to 54 patients indicates that thickness of the center of the cornea can affect the intraocular pressure (IOP). The researchers revealed that the there is no consistent relations between the two because corneal thickness is not an authentic reflection of laminar and scleral changes.

The article focuses on the relationship of the thickness of cornea and glaucoma. The relationship between central corneal thickness and intraocular pressure has come under increased scrutiny in glaucoma. A major study suggested a link between central corneal thickness (CCT) and the risk of developing primary open-angle glaucoma.

The article reports that the lowering of intraocular pressure is the only United States Food and Drug Administration-approved approach for treating glaucoma. Newer approaches are being studied to supplement present therapy in order to reduce the progressive loss of vision in glaucoma even further. Drugs under investigation include Memantine (Namenda), Brimonidine (Alphagan) and Glatiramer (Copaxone).

Reports on the research involving the effects of using laser in situ keratomileusis (LASIK) eye surgery on the detection and treatment of glaucoma. Possibility of affecting the measurements of intraocular pressure; Change in recommendation concerning medication therapy; Use of LASIK to reduce corneal thickness.

Reports that early treatment delays glaucoma progression according to the Early Manifest Glaucoma Trial conducted in 2002. Finding that a combination of laser surgery and eyedrops diminished the risk of glaucoma progression; Emphasis on the importance of lowering intraocular pressure as soon as possible after diagnosis.

Reports that latanoprost, one of the three prostaglandins most commonly recommended for the treatment of glaucoma, is as effective as the other two prostaglandins in reducing intraocular pressure (IOP) but has fewest side effects, according to the results of the first trial to compare the three topical prostaglandins. Earlier findings that prostaglandins are effective in lowering IOP with few side effects; Citation of eye redness as the most common of the side effects reported by patients.